CDC23 |
CDC23: Cell division cycle protein 23 homolog |
MARK2 |
IPI00718858 |
3.855 |
Evidence |
|
PPID |
PPID, CYP40, CYPD: 40 kDa peptidyl-prolyl cis-trans isomerase |
MAP3K14 |
MAP3K14, NIK: Mitogen-activated protein kinase kinase kinase 14 |
3.855 |
Evidence |
|
BRCA2 |
BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
3.855 |
Evidence |
|
SAT |
SAT1, SAT: Diamine acetyltransferase 1 |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
3.855 |
Evidence |
|
TIMP1 |
TIMP1, CLGI, TIMP: Metalloproteinase inhibitor 1 precursor |
LGALS3 |
LGALS3, MAC2: Galectin-3 |
3.855 |
Evidence |
|
CREBBP |
CREBBP, CBP: CREB-binding protein |
PHF8 |
PHF8, KIAA1111, ZNF422: PHD finger protein 8 |
3.855 |
Evidence |
|
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
CHUK |
IPI00556043 |
3.855 |
Evidence |
|
MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
RBM6 |
RBM6, DEF3: RNA-binding protein 6 |
3.855 |
Evidence |
|
POU2F1 |
POU2F1, OCT1, OTF1: POU domain, class 2, transcription factor 1 |
NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
3.855 |
Evidence |
|
DFFA |
DFFA, DFF1, H13, DFF45: DNA fragmentation factor subunit alpha |
CDC23 |
CDC23: Cell division cycle protein 23 homolog |
3.855 |
Evidence |
|
GRIN2A |
GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor |
TRPC3 |
N-terminally extended type 3 canonical transient receptor potential channel |
3.855 |
Evidence |
|
COPA |
COPA: Coatomer subunit alpha |
MAP3K14 |
MAP3K14, NIK: Mitogen-activated protein kinase kinase kinase 14 |
3.855 |
Evidence |
|
NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
CHUK |
IPI00556043 |
3.855 |
Evidence |
|
HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
3.855 |
Evidence |
|
CREBBP |
CREBBP, CBP: CREB-binding protein |
SREBF2 |
IPI00478350 |
3.855 |
Evidence |
|
MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
MAPK7 |
mitogen-activated protein kinase 7 isoform 1 |
3.855 |
Evidence |
|
GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
MNAR |
PELP1, HMX3, MNAR: Proline-, glutamic acid- and leucine-rich protein 1 |
3.855 |
Evidence |
|
TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
3.855 |
Evidence |
|
IPO7 |
IPO7: Uncharacterized protein IPO7 |
MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
3.855 |
Evidence |
|
STRN3 |
STRN3, GS2NA, SG2NA: Striatin-3 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
3.855 |
Evidence |
|
CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
AHNAK |
AHNAK: AHNAK protein |
3.855 |
Evidence |
|
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
RNPS1 |
RNPS1, LDC2: RNA-binding protein with serine-rich domain 1 |
3.855 |
Evidence |
|
JUN |
JUN: Transcription factor AP-1 |
TOP2B |
IPI00217709 |
3.855 |
Evidence |
|
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
NCOA3 |
IPI00220082 |
3.855 |
Evidence |
|
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
SLAMF1 |
SLAMF1, SLAM: Signaling lymphocytic activation molecule precursor |
3.855 |
Evidence |
|